The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. Services include: lead identification and development;chemistry and manufacturing;in vitro and in vivo preclinical safety, toxicology and biokinetics;and preclinical development, planning and evaluation.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272201100022I-0-27200003-7
Application #
8744245
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$53,310
Indirect Cost
Name
Sri International
Department
Type
DUNS #
009232752
City
Menlo Park
State
CA
Country
United States
Zip Code
94025